CASI Pharmaceuticals company info

What does CASI Pharmaceuticals do?
CASI Pharmaceuticals (NASDAQ:CASI) is focused on developing and commercializing innovative therapeutics and pharmaceutical products, primarily for the treatment of cancer and other life-threatening diseases. The company is traded on the NASDAQ stock exchange under the ticker symbol CASI. With a commitment to improving patient outcomes, CASI Pharmaceuticals has a diverse portfolio of products in various stages of development, from research and pre-clinical trials to late-stage clinical trials. Their operations encompass a wide range of activities, including drug discovery, development, manufacturing, and commercialization, with the objective to bring new and effective treatments to market. The company collaborates with partners globally to leverage cutting-edge science in pursuit of breakthrough treatments.
CASI Pharmaceuticals company media
Company Snapshot

Is CASI Pharmaceuticals a public or private company?

key
Ownership
Public

How many people does CASI Pharmaceuticals employ?

people
Employees
176

What sector is CASI Pharmaceuticals in?

pie chart
Sector
Health Care

Where is the head office for CASI Pharmaceuticals?

location pin
Head Office
Rockville, United States

What year was CASI Pharmaceuticals founded?

founded flag
Year Founded
1991
What does CASI Pharmaceuticals specialise in?
/Cancer Therapeutics /Biopharmaceutical Company /Evomela Product /Market Expansion /Research Development /Drug Manufacturing

What are the products and/or services of CASI Pharmaceuticals?

Overview of CASI Pharmaceuticals offerings
EVOMELA (melphalan) for conditioning treatment prior to stem cell transplantation in patients with multiple myeloma.
CNCT19, a CD19 CAR-T cell therapy for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.
CID-103, an anti-CD38 monoclonal antibody in development for multiple myeloma treatment.
BI-1206, a monoclonal antibody designed to enhance the efficacy of anti-PD1 therapy in solid tumors.

Who is in the executive team of CASI Pharmaceuticals?

CASI Pharmaceuticals leadership team
  • Dr. Wei-Wu  He Ph.D.
    Dr. Wei-Wu He Ph.D.
    Chairman & CEO
  • Dr. Wei  Zhang Ph.D.
    Dr. Wei Zhang Ph.D.
    President
  • Dr. Alexander A.  Zukiwski M.D.
    Dr. Alexander A. Zukiwski M.D.
    Executive VP & Chief Medical Officer
  • Ms. Kun  Qian
    Ms. Kun Qian
    VP & Global Controller
  • Ms. Chunhua  Wang
    Ms. Chunhua Wang
    Chief Operating Officer
  • Ms. Wei  Gao
    Ms. Wei Gao
    General Counsel
  • Dr. James E.  Goldschmidt Ph.D.
    Dr. James E. Goldschmidt Ph.D.
    Chief Business Development Officer
  • Mr. Hai  Huang
    Mr. Hai Huang
    Global Chief Commercial Officer